Drug Trial Radar · NCT07327359
A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
158
Planned (sponsor's estimate)
Start
Dec 4, 2025
Primary completion
Sep 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Olix Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Avance Clinical Pty Ltd.
- First posted
- Jan 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 59 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the safety, efficacy, tolerability, and pharmacokinetics (PK) of OLX72021 in medically healthy men with mild to moderate androgenetic alopecia.
Conditions
- Androgenetic Alopecia (AGA)
Interventions
OLX72021Drug
Low Dose
OLX72021Drug
Mid Dose
OLX72021Drug
High Dose
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- To investigate the incidence, type, severity, and relationship of adverse events (AEs)/serious AEs (SAEs), assessed using the CTCAE Version 5.0 (Phase 1b)Time frame: From baseline to end of study (Day 85)
- To assess local tolerability at intradermal (ID) injection site (Phase 1b)Time frame: From baseline to end of study (Day 85)
- To evaluate the change from baseline in non-vellus Target Area Hair Count (TAHC) at 24 weeks (Day 169) (Phase 2a)Time frame: Baseline to Day 169
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
Emeritus Research Sydney
Botany, New South Wales, Australia · Not yet recruiting
St George Dermatology and Skin Cancer Centre
Kogarah, New South Wales, Australia · Not yet recruiting
Genesis Research Services
Newcastle, New South Wales, Australia · Not yet recruiting
Emeritus Research Camberwell
Camberwell, Victoria, Australia · Recruiting
Sinclair Dermatology (t/a DIRECT)
East Melbourne, Victoria, Australia · Not yet recruiting
Institute for Skin, Health and Immunity
Mitcham, Victoria, Australia · Not yet recruiting
Optimal Clinical Trials Central
Grafton, Auckland, New Zealand · Not yet recruiting
Optimal Clinical Trials North Shore
North Shore, Auckland, New Zealand · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.